XML 37 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Equity Incentive Plans and Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Stock-based Compensation Expense

Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company’s stock-based awards, was as follows (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

 

 

Cost of revenue

 

$

110

 

 

$

131

 

 

$

416

 

 

$

421

 

Selling and marketing

 

 

253

 

 

 

399

 

 

 

1,377

 

 

 

1,261

 

Research and development

 

 

196

 

 

 

298

 

 

 

987

 

 

 

795

 

General and administrative

 

 

827

 

 

 

668

 

 

 

1,526

 

 

 

970

 

Total stock-based compensation

 

$

1,386

 

 

$

1,496

 

 

$

4,306

 

 

$

3,447

 

Stock Activity and Total Number of Shares Available for Grant

The following table presents the stock activity and the total number of shares available for grant as of September 30, 2025:

 

 

 

 

 

Balance at December 31, 2024

 

 

718,674

 

Plan Amendment

 

 

1,510,000

 

Options Cancelled

 

 

7,845

 

Restricted Stock Cancelled

 

 

105,758

 

Restricted Stock Granted

 

 

(428,706

)

Performance Shares Issued

 

 

(205,185

)

Balance as of September 30, 2025

 

 

1,708,386

 

Stock Option Activity

 

 

Options Outstanding

 

 

 

Number of
Shares
Underlying
Outstanding
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Outstanding at December 31, 2024

 

 

637,916

 

 

$

9.38

 

 

 

5.00

 

 

$

5,483,767

 

Options Granted

 

 

 

 

 

 

 

 

 

 

 

 

Options Exercised

 

 

(222,925

)

 

 

8.53

 

 

 

 

 

 

 

Options Forfeited

 

 

(7,845

)

 

 

10.19

 

 

 

 

 

 

 

Outstanding at September 30, 2025

 

 

407,146

 

 

$

9.83

 

 

 

3.65

 

 

$

2,963,241

 

Vested and expected to vest at September 30, 2025

 

 

407,146

 

 

$

9.96

 

 

 

3.65

 

 

$

2,963,241

 

Exercisable at September 30, 2025

 

 

407,146

 

 

$

9.96

 

 

 

3.65

 

 

$

2,963,241

 

Restricted Stock  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Restricted Stock Activity

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Nonvested restricted stock at December 31, 2024

 

 

605,356

 

 

$

15.92

 

Granted

 

 

428,706

 

 

 

15.27

 

Vested

 

 

(269,595

)

 

 

17.68

 

Shares forfeited

 

 

(105,758

)

 

 

14.37

 

Nonvested restricted stock at September 30, 2025

 

 

658,709

 

 

$

15.03